Volume 11, Number 2—February 2005
Letter
Community-associated Methicillin-resistant Staphylococcus aureus, Singapore
Li-Yang Hsu*
, Anne Tristan†, Tse-Hsien Koh*, Michéle Bes†, Jerome Etienne†, Asok Kurup*, Thuan-Tong Tan*, and Ban-Hock Tan*
, Anne Tristan†, Tse-Hsien Koh*, Michéle Bes†, Jerome Etienne†, Asok Kurup*, Thuan-Tong Tan*, and Ban-Hock Tan*
Table
Demographic and clinical data of patients with community-associated methicillin-resistant Staphylococcus aureus (MRSA)
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Date of MRSA isolation | Mar 2001 | Nov 2002 | Jan 2003 | Feb 2003 | Mar 2003 | May 2003 | Oct 2003 | Apr 2004 |
| Ethnicity | Indian | Filipino | Chinese | Chinese | Filipino | Chinese | Filipino | Chinese |
| Age | 52 | 20 | 38 | 37 | 31 | 56 | 21 | 33 |
| Sex | M | F | M | M | F | F | F | F |
| Coexisting conditions | Diabetes mellitus | – | – | – | – | Endometrial cancer | – | – |
| Infection type | Pneumonia, bacteremia | Hand abscess | Hand abscess | Hand abscess | Hand abscess | Hand abscess | Chin abscess | Abdominal wall abscess |
| Therapy* | IV vancomycin | I&D | I&D | I&D | I&D | I&D | I&D | I&D |
| Appropriate antimicrobial drug usage | Yes | No | No | No | No | No | No | No |
*Therapy: IV, intravenous; –, not applicable; I&D, incision and drainage of abscess.
Page created: April 28, 2011
Page updated: April 28, 2011
Page reviewed: April 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.